WASHINGTON, April 27 -- The U.S. Court of Appeals for the Federal Circuit issued the following order on March 27:
The parties jointly stipulate to dismiss the cross-appeal, Appeal No. 2023-2379, pursuant to Federal Rule of Appellate Procedure 42(b). Qiagen Sciences, LLC, Qiagen LLC, Qiagen Beverly, LLC, Qiagen Gaithersburg, LLC, Qiagen GmbH, Qiagen N.V., and Jonathan Arnold (collectively, "Qiagen") move unopposed for a 14-day extension of time, until April 15, 2024, to file the reply brief.
Upon consideration thereof,
IT IS ORDERED THAT:
(1) Appeal No. 2023-2379 is dismissed. The revised official caption for the remaining appeal, Appeal No. 2023- 2350, is reflected in this order.
(2) Each side shall bear its own costs as to Appeal ...